Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Pelvic Lymph Node Mapping in Rectal Cancer
NCT03204994Phase 2Terminated
- Sponsor
- Oxford University Hospitals
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green in rectal cancer, sponsored by Oxford University Hospitals. Started Aug 2017; status: terminated.
02
Drugs
indocyanine green
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03204994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204994.